ArticleThe clinical respiratory journal2025

An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System.

Hang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.